Last viewed: ONCY


Prices are updated after-hours



nasdaq:ONCY Oncolytics Biotech Inc.

ONCY | $1.05 -0.94% -3.35% 1.5K twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (8.9% 1m) (-13.4% 1y) (0.0% 2d) (1.9% 3d) (0.0% 7d) (NaN% volume)
Earnings Calendar: 2023-11-03
Market Cap: $ 79,190,756

http://www.oncolyticsbiotech.com
Sec Filling | Patents | 23 employees


Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.

pathogens   treatment  

add to watch list Paper trade email alert is off

Press-releases


Oncolytics Biotech® Announces Upcoming Presentations at the American Society of Clinical Oncology Annual Meeting
Published: 2024-04-25 (Just crawled : 12:00) - biospace.com/
ONCY | $1.05 -0.94% -3.35% 1.5K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

biotech meeting
Oncolytics Biotech® Advances Toward Registration-Enabling Trial for Pelareorep in Breast Cancer with Submission of Type C Meeting Request to FDA
Published: 2024-04-11 (Crawled : 12:00) - biospace.com/
ONCY | $1.05 -0.94% -3.35% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: 1.85% H: 0.0% C: 0.0%

biotech fda breast cancer for meeting trial submission
Oncolytics Biotech® Reports Fourth Quarter and Full Year 2023 Financial Results and Operational Highlights
Published: 2024-03-07 (Crawled : 21:00) - prnewswire.com
ONCY | $1.05 -0.94% -3.35% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: 2.88% H: 4.67% C: -1.87%

biotech year financial results
Oncolytics Biotech® Files Amendment to Initiate New Pancreatic Cancer GOBLET Cohort Supported by PanCAN
Published: 2024-03-05 (Crawled : 12:00) - prnewswire.com
ONCY | $1.05 -0.94% -3.35% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: 6.52% H: 6.12% C: 5.1%

biotech cancer pancreatic
Oncolytics Biotech® Appoints Patricia S. Andrews to its Board of Directors
Published: 2024-01-09 (Crawled : 14:00) - biospace.com/
ONCY | $1.05 -0.94% -3.35% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: -0.74% H: 0.74% C: -8.15%

biotech
Oncolytics Biotech® and SOLTI Present Positive Translational Data at SABCS
Published: 2023-12-07 (Crawled : 18:00) - biospace.com/
ONCY | $1.05 -0.94% -3.35% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: 2.92% H: 0.0% C: -0.71%

biotech positive sabcs
Oncolytics Biotech® and SOLTI Present Further Positive Pelareorep Translational Data at SITC
Published: 2023-11-03 (Crawled : 16:00) - prnewswire.com
ONCY | $1.05 -0.94% -3.35% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.56% C: -3.91%

biotech positive
Oncolytics Biotech® Reports Third Quarter 2023 Financial Results and Operational Highlights
Published: 2023-11-03 (Crawled : 11:00) - prnewswire.com
ONCY | $1.05 -0.94% -3.35% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: 0.0% H: 0.56% C: -3.91%

biotech financial results
Oncolytics Presents Positive Updated Pancreatic Cancer Data from GOBLET Phase 1/2 Study at ESMO
Published: 2023-10-23 (Crawled : 11:00) - prnewswire.com
ONCY | $1.05 -0.94% -3.35% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: 0.65% H: 9.94% C: 8.33%

positive cancer pancreatic study
Oncolytics Achieves Success Criteria for Efficacy in the Third-Line Colorectal Cancer Cohort of the GOBLET Study
Published: 2023-10-23 (Crawled : 11:00) - prnewswire.com
ONCY | $1.05 -0.94% -3.35% 1.5K twitter stocktwits trandingview |
Health Technology
| | O: 0.65% H: 9.94% C: 8.33%

success cancer study
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
61% 39%

Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M twitter stocktwits trandingview |

BHIL | $0.1793 -4.37% 19.24% 340K twitter stocktwits trandingview |
Agriculture, Forestry, Fishing ...

UMAC | $1.48 -1.33% 14.87% 20K twitter stocktwits trandingview |

CI | $352.28 -0.11% 13.53% 2 twitter stocktwits trandingview |
Health Services

CIG.C | $2.89 -1.37% 12.8% 2.3K twitter stocktwits trandingview |
n/a

MTH | $154.69 -2.21% 12.68% 450K twitter stocktwits trandingview |
Consumer Durables

HCP | News | $31.41 7.75% 11.26% 1.2M twitter stocktwits trandingview |

BMTX 4 | $1.545 0.98% 10.03% 2.5K twitter stocktwits trandingview |
Information

TAL | $12.26 0.57% 9.22% 12M twitter stocktwits trandingview |
Consumer Services

ASXC | $0.243 -2.41% 7.0% 1.1M twitter stocktwits trandingview |
Manufacturing


Last 48 Hours Insiders Buying
MNSB P 1470 | $15.89 -2.87% -3.02% 46K twitter stocktwits trandingview |
Finance
| 12:00
RKT P 347 | $12.55 -0.63% 1.12% 1.5M twitter stocktwits trandingview |
Finance
| 22:30
NWFL | News | $24.21 0.42% 1.99% 9.9K twitter stocktwits trandingview |
Finance
| 22:00
TGEN P 10000 | $0.68 -0.73% 39.71% 0 twitter stocktwits trandingview |
Utilities
| 20:01
RMCF | $3.55 0.28% 0.28% 7.1K twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar